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ABSTRACT
PROCESS-STRUCTURE-PROPERTY RELATIONSHIPS OF RESORBABLE
DESAMINO TYROSINE DERIVED POLYMERS: EFFECT OF BACKBONE
CHEMISTRY AND ASSEMBLY ON DRUG DELIVERY
by
Pinar Nebol
The selection the correct biomaterial for a specific medical application plays an important
role for the success of both application and the device. Since different applications
require different properties, investigation and improvement of biomaterials with different
properties are very important. L-tyrosine derived polymers enable the manipulation of the
properties of the material by changing backbone or pendent chain structure. L-tyrosine
derived polyarylate is one of the class of these materials.
This study investigates the behavior of the tyrosine derived polyarylates under in
vitro conditions. The change of structure caused by incubation in phosphate buffer
solution and the effect on the release of p-nitroaniline (PNA) (model drug) has been
investigated, primarily with differential scanning calorimetry (DSC). In addition the
release profile of PNA has been investigated by UV/visible spectroscopy.
Two different polyarylates were used. poly[(desaminotyrosine dodecyl esterl)
dodecondioate] designated Poly(DT 12, 10) and, poly[(desaminotyrosine octyl ester)
sebacate] designated Poly(DT 8, 8).
The results obtained from this study indicates that incubation caused significant
changes in the solid state organization of the Poly(DT 8, 8). Tg is seen in dry polymers
but disappears after the beginning of the incubation, indicating a phase change in the
polymer. The enthalpy of phase change of the Poly(DT 8, 8) increases and lay off state in
about one half a day. However, in contrast of Poly(DT 8, 8), the enthalpy of Poly(DT 12,
10) doesn't change significantly. According to these results, it is concluded that a phase
change occurs in Poly(DT 8, 8) by incubation. The incubation in dry conditions also
indicates a phase change in Poly(DT 8, 8), and this is accelerated by the presence of
moisture. The incorporation of the model drug did not affect the observed enthalpy
change of either of the polymers investigated.
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CHAPTER 1
INTRODUCTION
Biodegradable polymers have gained great importance over the last few year. This is
basically caused by the advantages of the degradable polymers over non-degradable
polymers. The first advantage is relatively mild foreign body reaction caused by
biodegradable polymers since they gradually degrade in the body and do not release
harmful residues if they are biocompatible. The second advantage is the ability to
regenerate tissue which can be available for the use in tissue engineering. In addition,
the properties they possess make them available to use for many medical implants,
drug delivery material [1].
Many different biodegradable polymers have been investigated for different
applications. The most widely used biodegradable polymers are polyglycolic acid,
polylactic acid and their copolymer polyglycolic acid/ polylactic acid (PGA, PLA,
PGLA) (i.e. polyester based plymers), polycaprolactone (PCL), polyhydroxybutrate
(PHB), polyhydrocybutrate-co-valerate (PHBV), polyorthoester and
polyethyleneoxide (PEO) [2, 4].
The properties of the material used in biomedical applications play a vital role
in the success of the application. Hence it's important to choose a material having
appropriate properties for specific applications. Therefore to be able to customize the
properties of the material for a desired application is desirable. Homo-poly(amino
acids) show good biocompatibility since they are developed from natural amino acids.
However, they have many disadvantages like poor degradation, processing
difficulties, and insolubility in common organic solvents [4, 5]. To overcome these
1
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Figure 2.4 The overlap ofDSC and temperature dependent FT-IR results of poly (DT 
12, 10) [6). 
From the results of Figure 2.4, it can be concluded that hydrogen bonding is 
affected by temperature. Combining the DSC and FTIR results, it is re,llsonable to 
assume that organization in Poly(DT 8, 8) is associated with H bonding [6). 
In the previous studies of the Jaffe group, it is seen that as methylene groups R 
and Y are small, then the material is amorphous If the number of methylene groups at 
these two sites increased, the material shows some level of non-crystalline 
organization and loses its strict amorphous properties [6, 36, 39). 
3increases, the ability of the material to reorganize itself increases [36]. The other
important result that obtained is the effect of moisture on the reorganization of these
polymers [38]. Yoo et al., investigated the thermal property of Poly(DT 8, 8) under
various conditions. In order to see the effect of moisture on the structure of Poly(DT
8, 8), samples were treated under both wet and dry conditions [38]. When the samples
were kept under vacuum and the moisture content is held to between 0.2-0.02%, a
single glass transition point were obtained under dry conditions. When the samples
were kept in aqueous environment an endothermic peak develops, and becomes more
distinguishable with larger energy. The author concluded these finding as the
plasticizing effect of moisture on structure formation of polyarylates; the presence of
moisture makes the material more flexible and ease its reorganization [38].
The aim of this study is to examine the structural changes of several L-
Tyrosine derived polyarylates under in-vitro conditions and relate this behavior to
drug elution profiles.
CHAPTER 2
THEORY and PRINCIPLE
2.1 Biomedical Materials and Their Applications
With increased lifestyle (stress level, accidents and change in food habit) there is an
increase in the individuals' need for biomedical applications. This augmentation
allows scientists to focus on biomedical products such as artificial organs,
biocompatible devices and products designed to increase the effect of drug therapy
[47]. Biomaterials can be defined in several different ways but in general it is said to
be a synthetic material which is used to replace a part or a function of a living system
contacting with living tissues, blood or biological fluid. It can also be defined as a
substance (other than drugs) or combination of substances which substitutes for the
role of any organ or tissue [1].
Several examples can be given for biomaterials produced and used in the
medical market. Table 2.1 and Table 2.2 summarize common applications of
biomaterials in both organs and body systems [1].
Table 2.1 Biomaterials in Organs [1]
Organ Examples
Hearth Cardiac pacemaker, artificial heart valve, total artificial heart
Lung Oxygenator machine
Eye Contact lens, intraocular lens
Ear Artificial staps, cochlea implant
Bone Bone plate, intramedullary rod
Kidney Kidney dialysis machine
Bladder Catheter and stent
4
5Table 2.2 Biomaterials in Body Systems [1]
System Examples
Skeletal Bone plate, total joint replacement
Muscular Sutures, muscle stimulator
Circulatory Artificial heart valves, blood vessels
Respiratory Oxygenator machine
Integumentary Sutures, burn dressing, artificial skin
Urinary Catheters, stent, kidney dialysis machine
Nervous Hydrocephalus drain, cardiac pacemaker, nerve stimulator
Endocrine Microencapsulated pancreatic islet cells
Reproductive Augmentation mammoplasty, other cosmetic replacement
The target function and the in-vivo environment of the material in the body
play an essential role in the selection of the raw material. Considering these factors
the biomaterial to be utilized, might be produced from metals, polymers, ceramics and
composites [1]. The material selected should meet all of the requirements for the
particular application [33]. The biomaterial selection is an important issue because if
the selection is inappropriate the health of the patient could be affected quite
adversely. This selection will depend on the properties of the material, design of the
device and the biocompatibility of the material used. Biocompatibility is basically the
reaction of the body to the foreign material. If the biocompatibility of the device is
low it will irritate the tissues in the environment and provoke an abnormal
inflammatory response [1].
Biocompatibility is an essential factor for biomedical devices to be safe for the
use as medical device [16]. Since each medical device has different requirements
appropriate material should be chosen for the specific application. In recent years,
scientists focused on biomaterials and devices produced from them and tried to
improve their performance. Biodegradable polymers played important roles in these
6studies and contributed a lot to their improvement. Through the development of
devices lots of problems occurred, such as the incompatibility of the foreign material
irritation of degradation products and infections caused from the operation [47].
Those problems might be overcome by the selection of the appropriate raw material.
The mechanical properties and the degradation behavior of the polymers is the
main criteria to be considered for selection depending on the requirements of the
specific devices [17]
Medical applications of biopolymers can be categorized into three subgroups;
• Extracorporeal uses; catheters, artificial kidney membranes, wound dressing
and artificial skin etc...
• Permanently Implanted Devices; Sensory, cardiovascular, orthopaedic and
dental devices etc...
• Temporary Implants; Degradable sutures, implantable drug delivery systems
etc... [47].
In the literature there are 4 different terms used to describe the disintegration
of the material in a living organism. These are biodegradation, bioerosion,
bioabsorption and bioresorption. It is not always easy to distinguish exactly by which
process materials disintegrate in a living organism. Simply biodegradation can be
referred as chemical degradation of the material caused by biological agent (enzyme,
cell or microorganisms) [33]. However, bioerosion is defined as conversion of water-
insoluble materials to fragments under physiological conditions. The terms
bioresorption and bioabsorption are used when a polymeric material or its degradation
products are removed by cellular activity in a living organism [33].
72.2 Drug Delivery Systems
The oral usage of the drug may not always be completely beneficial. However, the
local delivery of a drug provides advantages to the patient. Medicinal support is
always required for the patient after the application of the medical device. To increase
the efficiency of the drug, the studies on the targeted delivery of the drug have been
realized. The major advantage of the controlled local delivery of the drug is to
minimize the side effects [33]. Figure 2.1 illustrates the drug concentration in blood
plasma for the effectiveness of the drug.
Figure 2.1 Drug concentration following absorption of therapeutic agent as a function
of time. ( ) safe dose, unsafe dose (— — —), controlled release (— • — • —) [33].
Unsafe dosage exceeds the maximum tolerable drug concentration and reaches
a toxic over-dosing level. If a safe dose is used the concentration does not exceed the
max level. However, the effect continues for a short period of time and the drug is
ineffective because of under-dosing. Ideally, the controlled release of the drug
provides a constant release over the entire period of time (between overdose and
underdone concentrations, Figure 2.1). This provides a longer effect time in the
tolerable region where the drug is best utilized [33]. By the usage of the controlled
release, it is possible to avoid potential toxic over-dosing and periodic ineffective
under dosing [18].
8Degradable polymeric biomaterials can often enable the most effective use of
the drug, and sometimes its only effective use, by routes which include: providing
sustained effective systemic concentrations of the drug (i.e. avoiding the periodic
potentially toxic over-dosing that can occur at the beginning of a dosing period and
preventing the periodic ineffective under-dosing that can occur at the end of the
dosing period); providing high concentrations of the drug only in the local vicinity of
the drug-release depot, avoiding unwanted concentrations and effects of the drug at
locations far away from the disease treatment site; protecting the drug from the body's
metabolism and clearance mechanisms as the drug is being released; targeting the
drug to particular cells and sites within the body; and targeting the drug to particular
organelles and sites within individual cells [18].
2.2.1 Biodegradable Polymers in Drug Delivery
Biodegradable polymers are widely used in the drug releasing medical devices since
they have good biocompatibility and drug transport properties. Polyester based
polymers are the most frequently investigated degradable polymers for drug delivery
applications [19]. Local drug delivery systems are mainly used in the treatment of
cardiovascular disease, diabetes, orthopaedics, and cancer [20].
Basically the most widely used biodegradable polymers are; polyglycolic acid,
polylactic acid and their copolymer polyglycolic acid/ polylactic acid (PGA, PLA,
PGLA) (i.e. polyester based plymers), polycaprolactone (PCL), polyhydroxybutrate
(PHB), polyhydrocybutrate co valerate (PHBV), polyorthoester and
polyethyleneoxide (PEO). Although these biodegradable polymers show good
biocompatibility they might show significant inflammatory and proliferative response
in some studies [3]. They considerably increased the biocompatibility of the surface
of coated devices. However, they do not decrease noeintimal proliferation by
9themselves. Therefore drug loaded polymers have been used for a very long time [3].
Thus, polymeric materials can increase the surface biocompatibility of the devices
however; they will be more effective if they are used in accordance with a drug.
Biodegradable polymers in drug delivery have been used for different
purposes. Most frequently they are used for antibacterial purposes in medical implants
to prevent infections, in skeletal delivery systems, and in stent coating to prevent
restenosis and coagulation [21-23]. H. Gollwitzer et al., coated medical implants with
antibacterial poly D,L lactic acid. Kirschner-wires were coated by solvent casting.
The antibacterial effect was provided by Gentamicin & Teicoplain. The number of
viable bacteria was reduced in the antibiotics presence [21].
There are several studies with biodegradable polymers, which studies them as
a drug matrix for medical devices and implants [2, 3]. Five different biodegradable
synthetic polymers after implantation within porcine coronary artery are studied by
Van der Giessen et al. in the coating of stents. The polymers used were;
polycaprolactone (PCL), polyhydroxybutrate (PHB), polyhydrocybutrate-co-valerate
(PHBV), polyorthoester, polyethyleneoxide/polybutylene-terephtalate and
poly(glycolic acid) / poly(lactic acid). The results showed that all polymers induced a
significant inflammatory and proliferative response after 4 weeks and drug release is
achieved through disintegration of the polymer [42]. Lincoff et al. compared the drug
release from both low and high molecular weight Poly-L-lactic acid (PLLA).
According to the study, high molecular weight PLLA showed slower degradation and
consequently there was no evidence of acute or chronic inflammation [43].
In biomaterials the material properties are extremely important in order to
mimic the tissue that it will replace or in order to succeed in its specific application.
Some of the materials will require fast degradation some of them slow degradation,
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some of the products (like bone fixation devices) will require to bear load and some
systems (drug releasing systems) will require rubbery structures [7].
Kohn and Langer developed new biodegradable polymers that can be used in
vivo. The chemical structure of these polymers makes it possible to adjust the
properties of polymers according to the specific application [4]. One major type of
these polymers is L-Tyrosine derived polyarylates. The structure of these materials
allows for adjusting the properties of the materials by changing the length of the
backbone and pendent chain. The difference in these chains determines whether the
material is rubbery or glassy at a specific temperature, the mechanical properties and
degradation properties [4].
One important limitation for biodegradable polymers is the cytotoxicity of the
degradation products. For examples diphenols gives good mechanical strength to the
polymers when it is used in backbone However, polymers containing diphenol in their
backbone cannot be used in vivo since they are cytotoxic [5]. The widely utilized
biodegradable polymers derived from a—hydroxy acids (like poly-glycolic acid, poly-
lactic acids ) have similar limitation. Although they have approval for many
applications in the USA, their degradation products can still be limit their
applications. The acidic degradation product may cause the material to fail [8]. Kohn
and Langer used Tyrosine which is a major nutrient instead of diphenol in the
backbone of the polymer [5].
2.2.2 Chemical Structure of Polyarylates
Although some biodegradable polymers have FDA approval to be used in humans,
they still have disadvantages of irritation to the body because of the degradation
products. Since amino acids are naturally found in body, the idea of poly(amino acids)
as polymeric biomaterials have gained importance. Many of the poly(amino acid)
11
have failed because of inappropriate physical and mechanical properties, in addition
they still had immunogenic problems [2].
Tyrosine is an amino acid containing an aromatic hydroxyl group [5, 9]. In the
formation of tyrosine derived polymers it is used as an alternative to diphenols [5].
Non-cytotoxic nature of tyrosine enabled to produce non-cytotoxic tyrosine based
pseudo poly(amino acid) [2].
Tyrosine derived polyarylates are formed by 2 structural elements. The first
allows the modification of the backbone structure and the second forms the pendent
chain of the polymer [2]. It is seen in previous studies that variation in the size of the
backbone and side chain causes dramatic changes in structure and properties of the
polymers [ 1 0] .
The nomenclature of the desaminotyrosyle-tyrosine derived polyarylates has
been determined depending on the backbone and pendent structure of the polymer.
According to the number of methylene group in the backbone and side chain, the
name of the polyarylates can be determined. Poly(Desaminotyrosyl-tyrosine octyl
sebacate) have octyl group at the side chain and octyl ester component on side chain
derived from sebatic acid [6]. In order to facilitate to use of the name simple
abbreviations are used as Poly(DT R, Y) where DT stands for desaminotyrosyl-
tyrosine, R stands for number of hydrocarbons at the side chain and Y stands for
number of hydrocarbons in the backbone chain [6].
In this study three types of polyarylates are used: Poly(DTD dodecondioate),
Poly(DTO sebacate) and Poly(DTE succinate), designated Poly(12, 10), Poly(DT 8,
8) and Poly(2, 2), respectively. DTD stands for desaminotyrosine dodecyl ester, DTO
stands for desaminotyrosine octyl ester and DTE stands for desaminotyrosine ethyl
ester [6].
12
Figure 2.2 Tyrosine derived Polyarylate [5].
Figure 2.2 shows the chemical structure of the Desamino tyrosyl polyarylates
[5]. Change in polymer backbone is created by the change in diacid structure in
backbone and change in the diphenol component creates change in pendent chain.
That's how a large number of polymer types created possessing various properties [5].
2.2.3 Morphology of Polymers
Polymers can typically have two different types of phases in solid state. These are
amorphous and crystalline. However, polymers can not be completely crystalline and
they will posses unordered amorphous regions thus they are called semi-crystalline
[33, 34]. Figure 2.3 compares the behavior of the amorphous polymer and semi-
crystalline polymer. It also shows the morphology of semi-crystalline polymer; the
amorphous region in the crystalline region [34].
.-norphous ; f 
• 
stmicrIJshllin.: b 
• 
d 
Figure 2.3 Comparison of amorphous and semi-crystalline polymer behavior [34]. 
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The morphology of polymers is important criteria for determining the 
properties of the material to be used in medicine [33] . The degradation and drug 
release will be affected whether it is amorphous or semi-crystalline and also percent 
crystallinity of the material. Amorphous polymers will degrade faster compare to 
crystalline polymers because of faster erosion and the release of the drug will also be 
faster if release is dominated by degradation [35]. 
The morphology of the polymer can be complex and may have mofe than one 
phase in its structure. The material either crystalline or amorphous can have more 
than one distinct phase in its structure If a crystalline materials has more than one 
distinct phase it is called polymorphic materials. I an amorphous material has more 
than one distinct phase it is called polyamorphic material [40, 41]. Polymorphs are the 
materials possessing multiple crystalline phases with a phase boundary represented by 
phase equilibrium diagram. Therefore, there is a certain temperature and pressure that, 
free energies of two phases ·are equal and on one side one phase is more stable. 
Although this phenomenon is rarer for amorphous materials, there are examples that 
can be considered as polyamorphous materials [41]. Water is an example of 
polyamorphous materials and it is still under investigation by scientists [41]. If a 
----------------------~/ 
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polyamorphic material is used in any application to produce a medical device, how
the phases of the material changes should be considered in order to predict the
properties of the device. Form the previous studies poly(DT 8, 8) showed different
phase properties when it is exposed to different conditions [6, 24, 27, 36, 38, 39].
2.2.4 Drug Release Studies of L-Tyrsosine Derived Polyarylates and
Polycarbonates
Since L-tyrosine derived polyarylates are relatively new polymers, there are limited
resources in the literature on drug delivery. The majority of the existing studies are
published by J. Kohn and his research group.
Yu and Kohn used two model drugs to investigate the release behavior of
microspheres formed from Poly(DTB carbonate) and Poly(DTB carbonate)
polyethylene glycol (PEG) copolymer. Fluorescein isothiocyonate-dextran (FITC-
dextran) is used as high molecular weight hydrophilic model drug and p-nitroaniline
as low molecular weight hydrophobic model drug. According to the results, FITC-
dextran released with a small burst effect in the first hour then experienced a lag
period having very slow release during 14 days. For the case of p-nitroaniline the
release was much faster and presence of PEG accelerated the release of PNA [8].
In the literature there are studies with both L-tyrosine derived polyarylates and
polycarbonates testing the hemocompatible coating by incorporation of anticoagulant
into the coating. Huridin and prostacyclin were used as anticoagulant materials.
Carbon fibers coated with drug incorporated polymer coating and blank polymer
coating. Both showed decrease in coagulation compare to uncoated control fibers in
addition drug incorporated ones prevented formation of thrombin at the surface [5].
Another remarkable study is the intracranial delivery of dopamine with long
term controlled-release device which is made from Poly(DTH carbonate) [5]. Because
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of the drug-polymer relationship Poly(DTH carbonate) showed prolonged release.
The polymer matrix appeared to protect dopamine enabling prolonged release [5].
2.2.5 P-Nitroaniline as a Model Drug
In many studies in the literature p-nitroaniline (PNA) is used to model the drug
behavior [8, 12, 14, 15]. There are a couple of advantages in using a model drug
instead of using actual drugs. First it is cheaper compared to commercially available
drug and can also behave like drugs having similar chemical structure.
Cheng and his coworkers used PNA to investigate the release behavior of
cross-linked amino-acid containing poly-(anhydride-co-imide)s [14]. In another study
PNA served again as a model drug with poly(sebacic anhydride-co-ethylene glycol).
PNA was encapsulated into the polymer and release behavior was investigated under
pH 7.4 and 4.0 [15].
The other advantage of PNA is its yellow color which makes it easy to
monitor by simple UV/Visible sepectroscopy. This is one of the reason Kohn and
Fiordeliso chose PNA as a model drug to investigate the release profile from tyrosine
derived polyarylates [12]. PNA is also used in the study of Yu and Kohn. In the
release studies of tyrosine-PEG-derived poly(ether carbonate)s microspheres. PNA
served as low molecular weight hydrophobic model drug in this study [5, 8].
2.3 Thermal Analysis of Polymers
Differential scanning calorimetry is a technique widely used for thermal analysis of
materials. It applies constant heat on both sample and reference and measures the
change in temperature in both sample and reference [26]. For a material the change in
temperature will be the same with reference unless there is no endothermic or
exothermic reaction. If there is an exothermic reaction then the system uses the energy
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released as a result of this reaction. Thus the increase in temperature of the sample is
higher compare to the reference. If there is an endothermic reaction, then the change
in temperature in sample is less compared to the reference since the system uses more
energy to achieve the reaction [26].
Amorphous polymers or amorphous regions in polymers do not have enthalpy
of melting since amorphous structures experience a smooth transition from a glassy
state to a true liquid phase [31].
The structural behavior of various Desaminotyrosyle-Tyrosine derived
Polyarylates has been studied widely by the Jaffe group. Figure 2.4 shows the
behavior of Poly(DT 12, 10) with increasing temperature. It shows the overlap of
FTIR and DSC results. From the FTIR results at low temperatures at wavelength of
1648 cm-1 , strong hydrogen bonding can be seen. As the temperature increases, this
strong hydrogen bonding transforms to weak hydrogen bonding, and this is also seen
in the DSC results as two endothermic peaks. When the temperature increases further,
neither strong nor weak hydrogen bonding is distinguishable any more. Only free
amide carbonyl bond was dominant [6].
Figure 2.4 The overlap of DSC and temperature dependent FT-IR results of poly (DT
12,10) [6].
From the results of Figure 2.4, it can be concluded that hydrogen bonding is
affected by temperature. Combining the DSC and FTIR results, it is reasonable to
assume that organization in Poly(DT 8, 8) is associated with H bonding [6].
In the previous studies of the Jaffe group, it is seen that as methylene groups R
and Y are small, then the material is amorphous If the number of methylene groups at
these two sites increased, the material shows some level of non-crystalline
organization and loses its strict amorphous properties [6, 36, 39].
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(a) (b) 
Figure 2.5 X-Ray scattering data of (a) Poly (DT 2, 2) (b) Poly (DT 12, 10) [36]. 
Collins et aI., studied the thermal characterization ofpolyarylates Poly(DT 12, 
10) and Poly(DT 2, 2). Figure 2.5 shows the X-ray scattering data for Poly(DT 2, 2) 
and Poly(DT 12, 10). It is seen that both of the polymers showed a high angle peak 
around 20° of their 28 angle. This peak is considered as a van der Waals peak and 
indicates amorphous properties. However, Poly(DT 12, 10) showed also a low angle 
I 
peak unlike Poly(DT 2, 2). This peak is considered to be caused by long aliphatic 
, . 
chain in Poly(DT 12, 10), and considered to be a sign of some level of organization on 
the polymer, although it does not appear to have 3D periodic,ity"Iijce , .. C!),$tlllline 
structures [36] . This behavior is concluded with the existence of the complex 
amorphous structure formed by different types of phases [36]. 
This study revealed that, there are two modes of organization in the structure 
of Poly(DT 12, 10); Mode A and mode B. The polymer exists in mode A. at room 
temperature having a specific H bonding arrangement. As the temperature increases 
than it reorganize itself and transforms to mode B [36]. 
There are several thermal event happens during heating of Poly(DT 12, 10) 
displayed by Collins et aI., [36]. These events can be seen in Figure 2.6 which exhibit 
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the DSC result for POly(DT 12, 10) and Figure 2.7 which explains the events occur 
during heating ofthe polymer in the DSC. 
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Figure 2.6 Overlay of optical pattern and DSC Poly(DT 12, 10) [36]. 
During heating of Poly(DT 12, 10), four thermal events occur. The first one is 
the rotational relaxation occur in mode A at around 40°C, and is given as event I in 
Collins' study. As the temperature increases mode A transforms to mode B at around 
55°C and stated as event 2. If Poly(DT 12, 10) is continued to be heated a rotational 
relaxation occurs in mode B at. around 67°C in which is stated as event 3, If it is 
heated further, mode B transforms to an unorganized mode of aggregation which is 
called as mode U by Collins and his coworkers. This last event is called as event 4 
and occurs at around 85°C [36] . These series of events are displayed in Figure 2.7. 
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Figure 2.7 Free energy diagram for Poly(DT 12, 10) [36].
Considering these events occur during heating of Poly(DT 12, 10), in the study
it is concluded that Poly(DT 12, 10) has two modes of hydrogen bonding in it
structures and this modes depends on the temperature affecting the physical behavior
of the polymer [36]. The change in temperature causes the polymer changes its phase
from one mode to another and the change on these modes will affect the physical
behavior of the polymers [36]. Therefore it's important to be able to predict the mode
and the behavior of the change in mode of the polymer in order to predict the
properties of the material to be used in the production of a medical device. This
change in mode of organization the Poly(DT 12, 10) which is non-crystalline,
supported the idea of polyamorphism for this material having different modes of
amorphous aggregation [36].
Jaffe and his coworkers studied several different types of Polyarylates in
Medical Device Concept Laboratory (MDCL). In one of their studies they
investigated the dependence of the mesogenic order on the hydrogen bonding in the
structure of the polymers. The hydrogen bonding through the backbone amide linkage
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affects the organization of the internal aggregation of the polymer. According to their
IR results, they concluded that the polymer re-organize itself. This reorganization is
caused by the formation of hydrogen bonding of the esters through backbone of the
polymer [24]. They concluded that the presence of the different phases in the polymer
and the phase change between them will affect the performance of the polymer in-
vivo conditions [24]. Therefore, it's important to predict the behavior of these
polymers under in-vitro and in-vivo conditions.
CHAPTER 3
MATERIALS and METHODS
3.1 Materials
In this study two different L-tyrosine derived polymers were used: Poly(DTE
dodecondioate), Poly(DT 12, 10) and Poly(DTO sebacate), Poly(DT 8, 8) were kindly
purchased from New Jersey Center for Biomaterials and Medical Devices.
Tetrahydofuran (THF) from Sigma is used as polymer solvent for Poly(DT 12, 10)
and Poly(DT 8, 8). Soduim hydroxide from (NaOH) and potassium phosphate
monobasic from Fisher-Scientific are used to prepare phosphate buffer (PBS) solution
at pH 7.4. p-nitroaniline (PNA) purchased from Acros was used as model drug in drug
release analysis.
3.2 Methods
The methods used in this study can be grouped in to three subgroups. Thermal
analysis, degradation analysis of polyarylates and p-nitroaniline release analysis from
polyarylates.
Based on previous trials a fifteen percent polymer wt/v ratio is used to prepare
homogeneous polymer solutions. Five and 10% ratios had been used in preliminary
trials and it is seen that the viscosity was low. Fifteen percent have appropriate
viscosity to obtain suitable films. Glass plates were coated with Teflon sheets (with
adhesive one side). After obtaining homogeneous polymer solutions, polymers films
casted on these plates. The reason to use Teflon at coating surface is to be able to peel
off the films easily. A twenty mill stainless steel doctor blade was used for casting
each sample. Figure 3.1 shows the casted Poly(DT 8, 8) film with 10% PNA loading
and doctor blade.
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Figure 3.1 10% PNA loaded casted Poly(DT 8, 8) film on Teflon coated glass and 
stainless steel doctor blade. 
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Films are subjected to air drying for 24 hours and vacuum drying at 40°C in 
vacuum oven for additional 24 hrs. Dried films are than cut into 0.5 inch x 0.5 inch 
pieces to incubate phosphate buffer solutions. 
3.2.1 Incubation of Polymer Films 
Square polymer films were incubated in phosphate buffer solutions (PBS). PBS is 
prepared according to United States of Pharmacopedia (USP) standards at pH 7.4 
[25]. 0.2 M sodium hydroxide and 0.2 M potassium phosphate monobasic is used and 
mixed according to USP standards. The polymer films are incubated at 37°C in 25 ml 
, . 
of PBS solutions. The films are removed at specified times, rinsed with deionized 
water and stored at 37°C for three more hours and prepared for DSC analysis. 
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3.2.2 Differential Scanning Calorimetry
"Differential scanning calorimetry" is used in thermal analysis of the polymers. In
these experiment it is used to determine the enthalpy change of the material as a result
of the incubation of the polymer films. Q100 Differential scanning calorimetry (TA
Intrument) was used in the study. In the analysis, conventional DSC in heat-cool-heat
mode was used for scanning in dry N2 environment. Samples were encapsulated in
standard aluminum pans between 5-8 mg. The first heating cycle gives information
related to the effect of polymer processing [6]. The parameters used in DSC are
summarized in Table 3.1.
Table 3.1 DSC Parameters for Thermal Analysis of L-tyrosine Derived Polyarylates
Parameters Temperature
Start Temperature (°C) -20
Heating Rate (°C) 10
Maximum Temperature (°C) 130
Cooling Rate (°C) 10
Minimum Temperature (°C) -20
For each analysis, three repetitions have been performed to be able to see
repeatability and precision. For each time point, results has been investigated with
95% confidence interval and shown by error bars in each figures.
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3.2.3 Release of P-nitroaniline
The release profile of p-nitroaniline was monitored by uv/visible spectrophotometer.
Standard curve has been prepared using the absorbance values at 382 nm for different
PNA concentrations. The wavelength has been determined by scanning the solution
having highest concentration in the range of 200-700 nm and the maximum peak has
been found at 382 nm which is consistent with literature [14, 44-46]. The calibration
curve and concentration equation was given in Results and Discussion Chapter. Three
readings were performed for each sample and collection time points and absorbance
values were recorded for each polymer type and drug ratios.
3.2.4 Gel Permeation Chromatography Analysis
In order to analyze the molecular weight of the polymers and thus the release
mechanism of the drug, gel permeation chromatography (GPC) was used. GPC
analysis were performed in THF (1 mL/min) using a Waters Breeze system equipped
with a 717plus autosampler, a binary HPLC pump, a 2487 dual 1 absorbance detector,
and a 2414 refractive index detector. A series of styragel columns which were kept in
a column heater at 35 °C, were used for separation. The columns were calibrated with
PS standards.
Polymer films were dissolved in THF (which is an appropriate solvent for
these polymers for GPC analysis) and clear solution was obtained before GPC
analysis. The weight of the polymer films were between 5-8 mg each time. In order to
see the repeatability of the results random incubation times were selected and the test
was repeated for each polymer type having different drug ratio.
CHAPTER 4 
RESULTS and DISCUSSION 
4.1 Effects of Incubation on Assembly of L-tyrosine Derived Polyarylates 
4.1.1 Effects ofIncubation on Assembly 
The effects of incubation on assembly were investigated by DSC. The films collected 
at specific incubation times were run in DSC and their enthalpies were determined 
from endothermic peaks obtained during melting. 
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Figure 4.1 PSC Results of 1'01y(DT 8, 8) (0% PNA) with 0, 24 and 48 hrs of 
incubation. 
Figure 4.1 shows the DSC results for the first heating cycle for Poly(DT 8, 8) 
with zero PNA concentration. As shown, the endothermic peak of the films changes 
for different incubation times indicating change of the enthalpy. At 0 hrs incubation a 
small endothermic peak was seen at around 60°C; after 24 hrs of incubation the 
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endothennic peak became much sharper at around 63°C. The Tg almost disappears 
after incubation although it is apparent with the 0 hrs data point, consistent with 
results of Yoo [6]. The endothennic peak shows that the heat flow increases 
significantly for 24 and 48 hrs of incubation compared to zero hrs incubation. 
However, for Poly(DT 12, 10) the endothennic peaks do not change significantly as it 
can be seen in Figure 4.2. A sharp endothennic peak was seen at around 63°C and a 
very small shallow peak was seen at around 85°C. 
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Figure 4.2 DSC Results of Poly(DT 12, 10) (0% PNA) with 0, 23 and 45 hrs of 
incubation. 
Figures 4.3 and 4.4 show the enthalpy:.change of Poly(D~ 8, 8) and Poly(DT 
12, 10) respectively. The enthalpy values were calculated using linear baseline 
integration with TAU niversal Analysis. 
Incubation changes the enthalpy of Poly(DT 8, 8). In Figure 4.3 the 
exponential change in enthalpy of Poly(DT 8, 8) during the early stages of incubation 
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can be seen. It is also seen that the enthalpy increases and levels off after 
approximately 6 hrs. The change of the enthalpy with the incubation in a simulated 
aqueous body environment suggests the phase change of the polymer, reorganization 
in internal molecular aggregation, will occur in the first few hours of in-vivo use. 
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Figure 4.3 Enthalpy change ofPoly(DT 8, 8) with incubation with 0% PN'A. 
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Figure 4.4 Enthalpy change ofPoly(DT 12, 10) with incubation with 0% PNA. 
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Unlike Poly(DT 8, 8), the enthalpy values of Poly(DT 12, 10) do not change 
significantly with incubation. Figure 4.4 displays that; they follow a relatively 
constant pattern. 
In Figure 4.5 the enthalpy values for these two polymers without PNA content 
was compared. As seen, the enthalpy does not change significantly in Poly(DT 12, 
10), but Poly(DT 12, 10) has higher level off enthalpy value which is 30.5-31 Jig 
compare to Poly(DT 8, 8) which is approximately 19.5-20 Jig. 
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Figure 4.5 Enthalpy change comparison of Poly(DT 8, 8) and Poly (12, 10). 
To be able to see the effect of incubation in the PBS for Poly(DT 8, 8), the 
polymer films also were tested under vacuum environment at 37°C. Figure 4.6 
exhibit the enthalpy change of the samples under vacuum. According tC\l the results, 
Poly(DT 8, 8) also has an increase in enthalpy under vacuum but it is seen that the 
increase in enthalpy in PBS is faster compared to increase in enthalpy under vacuum. 
Under vacuum Poly(DT 8, 8) reveals a delay in the increase ofthe enthalpy. 
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Figure 4.6 Enthalpy change of Poly(DT 8, 8) with 0% PNA under vacuum. 
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Figure 4.7 Comparison of thermal behavior ofPoly(DT 8, 8) after 24 hrs of vacuum 
and incubated conditions. 
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In Figure 4.7 the comparison of thermal behavior of Poly(DT 8, 8) can be seen
after 24 hrs of incubation at different conditions. The green line shows the behavior of
the polymer film kept for 24 hrs at 37°C under vacuum. The black line shows the
behavior of the polymer films incubated for 24 hrs in the PBS at 37°C. The Figure
displays the difference on thermal behavior of Poly(DT 8, 8) treated differently. The
film incubated in the PBS shows a sharp enthalpic peak at around 63.87 °C whereas
polymer film kept under vacuum shows smaller enthalpic peak around 60°C. The
glass transition point for Poly(DT 8, 8) under vacuum is more distinguishable. This
difference can be a result of faster appearance of the phase change in Poly(DT 8, 8)'
for the samples incubated in PBS. One can conclude that moisture increases the rate
of the phase change of Poly(DT 8, 8) and causes reorganization in its structure. In
t
Appendix D the DSC results for Poly(DT 8,8) with 0% PNA under dry conditions for
each incubation time point were given for the first repetition.
It is also know that the increase in phase change enthalopy of Poly(DT 8, 8)
occurs in any conditions. It also occurs when it is kept in room conditions. Although,
It is not investigated in terms of kinetics in the study it is seen that if the polymer is
kept in room conditions, this enthalpy change also occurs. The storage conditions of
the polymers only affects how fast this change occurs.
In this study Poly(DT 8, 8) exhibited phase changing behavior having different
rate, depending on environmental conditions. Consistent with the previous studies of
Jaffe and his group, Initially Poly(DT 8, 8) has similar structure with Poly(DT 2, 2)
showing amorphous properties. After incubation Poly(DT 8, 8) reorganizes itself and
gain similar characteristic to Poly(DT 12, 10) [24, 27, 36, 38 ,39].
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4.1.2 Effect of Drug Loading Combined witb Incubation on Assembly 
The effect of drug loading on polymer assembly has been investigated by 
incorporation of model low molecular weight hydrophobic drug p-nitroaniline for 
both Poly(DT 8, 8) and Poly(DT 12, 10). Two different polymer-to-drug (wt\wt) 
ratios were used; 5% and 10%. 
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Figure 4.8 Enthalpy change ofPoly(DT 8, 8) with incubation with 5% PNA . 
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Figure 4.9 Enthalpy change ofPoly(OT 8, 8) with incubation with 10% PNA. 
Figures 4.8 and 4.9 exhibit the enthalpy change of the 5% and 10% drug 
loaded Poly(OT 8, 8) by incubation respectively. As can be seen, they follow similar 
pattern. Similar to 0% drug loaded poly(OT 8, 8) films, enthalpy incre~es gradually 
• 
and reaches a constant value after incubation of approximately half a day. 
Figure 4.10 shows the comparison of the enthalpy change of Poly(DT 8, 8) 
films having different drug loading ratios. It is seen that the enthalpy of the drug 
incorporated films tends to have higher values compared to blank samples, especially 
for 10% PNA loaded samples. In terms of the patterns that follow, the drug loaded 
samples and blank samples do ·not differ significantly, which shows that the rate and 
the behavior of the phase change ofthe Poly(DT 8, 8) films has not been affected by 
drug incorporation. In Appendix A, Band C the OSC results for Poly(OT 8,8) with 
0%, 5% and 10% PNA for each incubation time point were given for the first 
repetition respectively. 
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Figure 4.10 Enthalpy change of Poly(DT 8, 8) with incubation with 0% 5% and 10% 
PNA. 
Figures 4.11 and 4.12 shows the enthalpy change of the 5% and 10% drug 
loaded Poly(DT 12, 10) by incubation respectively. Similar to Poly(DT 8, 8) the drug 
I 
loaded samples for Poly(DT 12, 10) as well shows similar behavior with bfank films. 
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Figure 4.11 Enthalpy change of Poly(DT 12, 10) with incubation with 5% PNA. 
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Enthalpy Change of Poly(DT 12,10) with 10% PNA Loading 
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Figure 4.12 Enthalpy change ofPoly(DT 12,10) with incubation with 10% PNA. 
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Figure 4.13 Enthalpy change of Poly(DT 12, 10) with incubation with 0% 5% and 
10%PNA. 
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Figure 4.13 shows the comparison of enthalpy change between drug 
incorporated samples and blank Poly(DT 12, 10) samples. Consistent with the result 
of Poly(DT 8, 8); drug incorporated samples also experience the similar behavior in 
terms of rate and pattern of the enthalpy change by incubation but the drug 
incorporated samples tends to have slightly higher enthalpy especially for 10 % PNA 
containing films. In Appendix E, F and G the DSC results for Poly(DT 12, 10) with 
0%, 5% and 10% PNA for each incubation time point were given for the first 
repetition respectively. 
In order to understand better the effect of PNA incorporation into the both 
Poly(DT 8, 8) and Poly(DT 12, 10), PNA has also been tested with DSC. The DSC 
parameters used were the same for DSC run except the highest temperature which is 
selected as 165°C to make sure that is slightly above the melting temperature of the 
p-nitroaniline. The melting temperature of PNA is 149°C. Figure 4.14 shows the 
DCS result for PNA powder. 
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Method: HeatICoolIHeat 
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Figure 4.14 DSC Result for p-nitroaniline in powder form. 
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DSC result for PNA shows a single endothermic peak at the melting
temperature of the model drug. There is no peak at the temperature that both Poly(DT
12, 10) and Poly(DT 8, 8) has endothermic peak. According to this result, one can
conclude that the slight increase in the enthalpy of the drug incorporated polymers
was not caused by the drug itself but the effect of the drug addition on the structure of
the resulting polymeric films.
4.2 Gel Permeation Chromatography Results
Gel permeation chromatography is a chromatographic technique that separates the
molecules depending on their size. It does not separate them directly depending on
their molecular weight but their hydrodynamic volume. Then molecular weight of the
samples can be determined using different standards. In this study polystyrene
standards were used. The larger the molecular weights the faster it came out from the
column since smaller molecules are retarded in the column. In order to see change in
molecular weight of the polymers Gel Permeation Chromatographic analysis was
performed.
The results showed that the molecular weight distribution range is quite broad
since the peak obtained for each sample was not sharp which indicates large
molecular weight distribution. This is an expected result for complex structures like
polymers. It is reasonable to consider that 5-10% change in molecular weight can not
be considered as change in molecular weight and conclude that there is no change and
there is no degradation during incubation.
Molecular Weight of Poly(DT 8, 8) with 0% PNA Incubated in 
PBS 
80000 
70000 • • • • • • • 
60000 
~ 50000 
S is 40000 
~ 30000 
20000 
10000 
0 
0 2 4 6 8 10 12 14 
Time (days) 
Figure 4.15 Molecular weight of incubated Poly(DT 8, 8) with 0% p-nitroaniline. 
80000 
70000 
60000 
'iii' g 50000 
-~ 40000 
~ 30000 
:::!i! 20000 
10000 
Molecular Weight of Poly(DT 8, 8) with 5% PNA 
Incubated in PBS 
• 
• • • • • • • 
I 
( 
I. Poly(DT 8, 8) 5% PNA 1 
o +---------,----------.---------,--------~ 
16 
o 5 10 
Time (days) 
15 20 
, 
Figure 4.16 Molecular weight of incubated Poly(DT 8, 8) with 5% p-nitroaniline. 
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Molecular Weight of Poly(OT 8, 8) with 10% PNA Incubated in 
PBS 
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Figure 4.17 Molecular weight of incubated Poly(DT 8, 8) with 10% p-nitroaniline. 
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Figures 4.15, 4.16 and 4.17 show the change in molecular weight of the 
Poly(DT 8, 8) with 0%, 5% and 10% PNA respectively by incubation in PBS. All 
three figures indicate that the change in molecular weight is negligible during 
;' 
incubation time. Therefore one can conclude that the release of the p-nitroaniline 
occurs with diffusion controlled manner rather that degradation controlled manner . 
. -
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Figure 4.18 Molecular weight of incubated Poly(DT 12, 10) with 0% p-nitroaniline. 
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Figure 4.19 Molecular weight of incubated Poly(DT 12, 10) with 5% p-nitroaniline. 
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Moloecular Weight of Poly(DT 12, 10) with 10% PNA Loading 
60000 
• • • • 50000 • • • • 
_ 40000 
.. 
" 0 
-~ 30000 
~ 
:;; 20000 
10000 
0 
0 5 10 15 20 25 
Time (days) 
Figure 4.20 Molecular weight of incubated Poly(DT 12, 10) with 10% p-nitroaniline. 
Figures 4.18, 4.19 and 4.20 show the molecular weight change during 
incubation of the Poly(DT 12, 10) with 0%, 5% and 10% PNA respectively. From 
;' 
each figure it can be concluded that the molecular weight of the polymer films stays 
constant during the incubation since the change is smaller than 10% for Poly(DT 12, 
10) similar to Poly(DT 8, 8). Since the molecular weight of Poly(DT 12, 10) stays 
constant it can be concluded that the release from Poly(DT 12, 10) is also controlled 
by diffusion. 
4.3 P-nitroaniline .~~lease Results 
The release of PNA was monitored by UVIVis spectrophotometer. The calibration 
curve has been constituted with different concentrations and the amount of PNA 
released to the incubation solution was calculated using the equation obtained from 
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that cal ibration curve. The equation obtained is given below in Equation 1 and the 
calibration curve is given in Figure 4.21. 
C[PNA 1 = 0.0099 * Absorbance Equation (1) 
The concentration of p-nitroaniline has been calculated using the Equation I. 
The weight of PNA has been calculated as mg in the PBS, and the weight percentage 
of the PNA released from the film has been calculated. For this calculation it is 
assumed that the drug has been uniformly dissolved in the polymer film and polymer 
to drug ratio (wtlwt) is same in every part of the films. 
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Figure 4.21 Concentration absorbance relatiori~hips for model drug P-nitroaniline. 
The release profile of PNA from 10% (polymer/drug wtlwt) drug containing 
Poly(DT 8,8) and Poly(DT 12, 10) is shown in Figure 4.22 and Figure 4.23 
respectively. As seen from the both Figure, p-nitroaniline releases quite quickly. The 
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time length requires for Poly(DT 12, 10) to reach equilibrium is shorter compare to 
Poly(DT 8, 8). Poly(DT 12, 10) reaches its equilibrium concentration at about 360 
min whereas, Poly(DT 8, 8) reaches its equilibrium concentration approximately in 
400 min (6-7 hrs). Figure 4.24 displays the comparison of the release profile of PNA 
from both Poly(DT 12, 10) and Poly(DT 8, 8). The difference in time length required 
to reach the equilibrium can be seen well in Figure 4.24. It's remarkable that the 
length of time that the release reaches equilibrium from the polymer is close to the 
length of time that the change in enthalpy in the Poly(DT 8, 8) films reaches steady 
state. Approximately 85.5% of PNA released from 10% PNA loaded Poly(DT 8, 8) 
and 92% of PNA released from 10% PNA loaded Poly(DT 12, 10). Poly(DT 12, 10) 
has slightly higher total release compared to Poly(DT 8, 8). 
Release of PNA from 10% PNA loaded Poly(OT 8, 8) 
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Figure 4.22 Release profile of p-nitroaniline from 10% drug containing Poly(DT 8, 
8). 
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PNA Release From 10% PNA loaded Poly(OT 12, 10) 
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Figure 4.23 Release profile ofp-nitroaniline from 10% drug containing Poly(DT 12, 
10). 
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Figure 4.24 Comparison of the release profile of p-nitroaniline from 10% drug 
containing Poly(DT 8, 8) and Poly(DT 12, 10). 
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The release profile of PNA from 5% (polymer/drug wtlwt) drug containing 
Poly(DT 8,8) and Poly(DT 12, 10) is shown in Figure 4.25 and Figure 4.26 
respectively. Similar to 10% PNA loaded samples the release is very quick and PNA 
concentration reaches equilibrium in a very short period of time. In addition similar to 
10% loaded samples the time length requires for Poly(DT 12, 10) to reach equilibrium 
is shorter compare to Poly(DT 8, 8). Poly(DT 12, 10) reaches its equilibrium 
concentration at about 400 min whereas, Poly(DT 8, 8) reaches its equilibrium 
concentration approximately in 600 min (6-7 hrs). Figure 4.27 displays the 
comparison of the release profile of PNA from both Poly(DT 12, 10) and Poly(DT 8, 
8). Approximately 81% of PNA released from 5% PNA loaded Poly(DT 8, 8) and 
89% of PNA released from 5% PNA loaded Poly(DT 12, 10). Although total percent 
releases are very close to each other, Poly(DT 12, 10) has slightly higher release 
compared to Poly(DT 8, 8) as in the case of 10% drug loaded samples. 
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Figure 4.25 Release profile ofp-nitroaniline from 5% drug containing Poly(DT 8, 8). 
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P-nitroaniline Release from 5% PNA loaded Poly(DT 12, 10) 
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Figure 4.26 Release profile of p-nitroaniline from 5% drug containing Poly(DT 12, 
10). 
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Figure 4.27 Comparison of the release profile of p-nitroaniline from 5% drug 
containing Poly(DT 8, 8) and Poly(DT 12, 10). 
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4.4 Discussion
According to the DSC results, Poly(DT 12, 10) showed an endothermic peak upon
heating and an exothermic peak upon cooling; Poly(DT 8, 8) on the other hand
showed only an endothermic peak consistent with previous work [24, 36]. Consistent
with the previous study of Collins et al., Poly(DT 12, 10) doesn't show a change in
heat capacity upon heating that could be considered as a glass transition point [36],
although Poly(DT 8, 8) showed a change in heat capacity around 15°C that can be
considered as glass transition temperature. Yoo et al. investigated the effect of the
water treatment for different molded polyarylates of varying backbone chain lengths,
including the Poly(DT 8, 8) composition. Similar to this study, the glass transition
point is observed in the second DSC heating while only a sharp endothermic peak is
observed in the first heating cycle [27]. The disappearance of the Tg point with the
increase in the endothermic melting peak upon heating indicates reorganization in
Poly(DT 8, 8) during incubation in the PBS.
A number of desaminotyrosil derived polymers have been studied by Jaffe's
group. Unordered Poly(DT 2, 2) and Poly(DT 2, 4) will behave as amorphous
polymers and Poly(DT 12, 10) as ordered will behave as an organized. Therefore
Poly(DT 12, 10) should have a slower elution time compared to amorphous polymers.
Poly(DT 8, 8) on the other hand, will first behave as an amorphous polymer; then
depending on the application and storage conditions it will reorganize itself and it will
have a structure similar to Poly(DT 12,10), and the release should change. Thus it will
show changing elution profile which should be considered upon producing a medical
device requiring specific properties. Depending on these facts, it was expected that
Poly(DT 12, 10) would show slower elution profile compared to Poly((DT 8, 8).
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However, on the contrary it showed a faster elution profile and reached equilibrium
faster than Poly(DT 8, 8).
The rate of reorganization in Poly(DT 8, 8) has been investigated and the
results showed that it experiences very fast exponential ordering in PBS at 37°C and
reaches steady state value in almost half a day. Initially it has an fully amorphous
structure and with incubation it reorganizes itself in a half a day. However, when is
kept under vacuum at 37°C, it showed much slower reorganization; and it experienced
slow reorganization after approximately one and a half day. The change in polymer
also shows that the storage conditions of a device produced from Poly(DT 8, 8) are
also extremely important in terms of internal aggregation of the polymer and this
should play important role for the elution profile of a drug and the degradation rate of
the polymer. The effects of temperature and moisture on the ordering of Poly(DT 8, 8)
have already been studied by Yoo et al. [6]. It has been seen that the moisture content
of the polymer is directly related to the structural change and the endothermic peak
formation in Poly(DT 8, 8) and also that with moisture, Poly(DT 8, 8) experiences
easier structural reorganization [6]. The previous results are consistent with the
current study indicating that the incubation of the Poly(DT 8, 8) increases the speed of
the phase change.
In this study the effect of the drug incorporation on the structural behavior of
both polymers has also been investigated. The results indicate that the incorporation
of a low molecular weight model drug has not been significantly affected the
structural behavior (the shape of the enthalpy change), but the drug containing films
tends to have slightly higher enthalpy compared to blank samples for both polymers
especially for 10% loading.
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The DSC result for PNA powder showed an endothermic peak at about 149-
150 °C which is the melting temperature of p-nitroaniline. The results suggest that the
increase in enthalpy of the poly(DT 8, 8) and Poly(DT 12, 10) casted films is not
caused by the drug itself. It might be the result of the effect of the drug loading on the
structure of the material. However, this hypothesis needs further analysis.
According to the results obtained from the GPC analysis, the change in
molecular weight of the polymer films during 10-15 days of incubation is negligible
as expected for both Poly(DT 8, 8) and Poly(DT 12,10). Therefore it is clear that the
release of the model drug, p-nitroaniline, is controlled by diffusion for both
polyarylate types. This result is consistent with the previous studies of the Kohn
group.
The release of the model drug is quite fast and reaches constant concentration
in almost 6-7 hours in both cases. However, Poly(DT 12, 10) releases faster compare
to Poly(DT 8, 8) which was not an expected result. It was expected that the initial
amorphous structure of Poly(DT 8, 8) would cause faster release in the beginning.
However since the reorganization of the Poly(DT 8, 8) is fast, one can conclude that it
is not an effect for the release of a material. In other words reorganization is too fast
to be a significant effect in the release profile. Then the release should be a result of
internal molecular structure. From previous studies it is known that the reorganization
in polyarylates is associated with hydrogen bonding [6]. It is also clear that Poly(DT
12, 10) is a larger monomer compared to Poly(DT 8, 8) since there are more
methylene group in both backbone and side chain structure [6]. Hence when hydrogen
bonding occurs the space between molecules will be larger in Poly(DT 12, 10)
compared to Poly(DT 8, 8) which will create more space for drug to move. As
indicated before it is also clear that the elution occur by diffusion. Then It is
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reasonable for Poly(DT 12, 10) to have faster since PNA molecules can move easier.
As mentioned before from the previous studies it is known that Poly(DT 2, 2) and
Poly(DT 2, 4) does not show any hydrogen bonding associated reorganization. They
remain amorphous. The reason for this might be that the shorter the molecule the less
flexible it is and the more difficult to make hydrogen bonding. As chains length
increases Polyarylates starts to form hydrogen bonding in their internal structure.
Figure 4.28 displays the 5% model drug remaining in the polymer films after
incubation in PBS. The elution stops at approximately 400 min for 5% drug loaded
samples of Poly(DT 12, 10) and 600 min for Poly(DT 8, 8).
Figure 4.28 %Drug Remaining in 5% PNA loaded Poly(DT 12, 10) and Poly(DT 8,
8).
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Figure 4.29 %Drug Remaining in 10% PNA loaded Poly(DT 12, 10) and Poly(DT 8,
8).
Figure 4.29 displays the 10% model drug remaining in the polymer films after
incubation in PBS. The elution stops at approximately 360 min for 10% drug loaded
samples of Poly(DT 12, 10) and 400 min for Poly(DT 8, 8).
Figure 4.30 shows the release profile from 5% PNA loaded Poly(DT 8, 8), as
seen it shows almost constant release through the release time. In Figure 4.31 the
release profile of 5% PNA loaded Poly(DT 12, 10) can be seen. Unlike Poly(DT 8, 8),
Poly(DT 12, 10) showed almost instant release of PNA. It showed a release profile
like a burst effect.
Figure 4.30 Drug Release from 5% PNA loaded Poly(DT 8, 8).
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Figure 4.31 Drug Release from 5% PNA loaded Poly(DT 12, 10).
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Figure 4.32 and 4.33 displays the release profile of 10% PNA loaded Poly(DT 8, 8)
and Poly(DT 12 10), respectively. Both of the polymers showed an instantaneous
release when they are loaded with 10% PNA; with 10% loading Poly(DT 8, 8)
showed a difference in release behavior. It released the drug similar to Poly(DT 12,
10) like burst effect. From this result one can conclude that drug loading percentage is
important in terms of release behavior. 10% loading can be too much for Poly(DT 8,
8) and that might be the reason for the fast release.
Figure 4.32 Drug Release from 10% PNA loaded Poly(DT 8, 8).
Figure 4.33 Drug Release from 10% PNA loaded Poly(DT 12, 10).
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CHAPTER 5
CONCLUSION
In this study the effect of incubation on Poly(DT 8, 8) and Poly(DT 12, 10) was
investigated and the results associated with the drug release properties of both
materials. In addition the degradation behavior of the polymers has been investigated.
DSC results showed that Poly(DT8, 8) has amorphous structure and reorganize
during incubation and gain a non-crystalline ordered structure. Unlike Poly(DT 8, 8),
Poly(DT 12, 10) has an ordered structure similar to steady state structure of Poly(DT
8, 8). This result is consistent with the previous studies carried out by MDCL lab.
In order to investigate the effect of structure on the release properties on the
polymers, model drug p-nitroaniline (PNA) was used. The release of the drug is a
diffusional phenomenon which was shown by Gel Permeation Chromatography
analysis. The change in molecular weight during the release time of was negligible,
which will reveal that the release is not a result of degradation of the polymers.
The elution profile has been monitored by using Uv/Visible
spectrophotometer. The elution of the PNA is very fast as it was expected according
to the previous studies in the literature. The release is even faster from Poly(DT 12,
10) for both 5% and 10% drug ratios, which was an unexpected result in this study.
The percent release from 5% loaded samples was 81% and 89% for Poly(DT 8, 8) and
Poly(DT 12, 10) respectively and from 10% loaded samples it was 85.5% and 92 %
for Poly(DT 8, 8) and Poly(DT 12, 10) respectively.
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APPENDIX A 
RAW DATA OF DSC RESULTS OF POLY(DT 8, 8) WITHOUT DRUG 
LOADING 
DSC results of 0% p-nitroaniline loaded Poly(DT 8, 8) and measured enthalpy of 
phase change. 
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Figure A.l De S result for 0 hours mcuated Poly(DT 8, 8) wIth 0% PNA. 
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FIgure A.5 DeS result for 6 hours mcuated Poly(DT 8, 8) with 0% PNA. 
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Figure A.6 DeS result for 17 hours mcuated Poly(DT 8, 8) with 0% PNA. 
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Figure A.7 DeS result for 21 ·hours mcuated Poly(DT 8, 8) with 0% PNA. 
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Figure A.10 DeS result for 42 hours mcuated Poly(DT 8, 8) with 0% PNA. 
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Figure A.IS DeS result for 89 hours mcuated Poly(DT 8, 8) with 0% PNA. 
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APPENDIXB 
RAW DATA OF Dse RESULTS OF POLY(DT 8, 8) WITH 5% DRUG 
LOADING 
DSC results of 5% p-nitroaniline loaded Poly(DT 8, 8) and measured enthalpy of 
phase change. 
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Figure 8.1 DeS result for 0 hours incuated Poly(DT 8, 8) with 5% PNA. 
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FIgure 8.2 DCS result for 1 hour !neuated Poly(DT 8, 8) with 5% PNA. 
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FIgure B.3 DCS result for 2 hours !neuated Poly(DT 8, 8) with 5% PNA. 
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FIgure B.4 DCS result for 3 hours mcuated Poly(DT 8, 8) with 5% PNA. 
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Figure B.5 DCS result for 4 hours incuated Poly(DT 8, 8) with 5% PNA. 
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Figure B.6 De S result for 6 hours mcuated Poly(DT 8, 8) with 5% PNA. 
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Figure B. 7 DCS result for 8 hours mcuated Poly(DT 8, 8) with 5% PNA. 
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Figure B.8 De S result for 18 hours 6 mms mcuated Poly(DT 8, 8) with 5% PNA. 
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Figure B.9 DeS resul t for 21 hours mcuated Poly(DT 8, 8) with 5% PNA. 
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FIgure B.lO DCS result for 32 hours !ncuated Poly(DT 8,8) with 5% PNA. 
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Figure B.ll DCS result for 48 hours incuated Poly(DT 8, 8) with 5% PNA. 
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Figure B.12 DeS result for 72 hours incuated Poly(DT 8, 8) with 5% PNA. 
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Figure B.14 DeS result for 144 hours incuated Poly(DT 8, 8) with 5% PNA. 
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Figure B.IS DeS result for 1'68 hours incuated Poly(DT 8, 8) with 5% PNA. 
APPENDIXC 
RAW DATA OF DSC RESULTS OFPOLY(DT 8, 8) WITH 10% DRUG 
LOADING 
Dse results of 10% p-nitroaniline loaded Poly(DT 8, 8) and measured enthalpy of 
phase change. 
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FIgure C.l DeS result for 0 hours mcuated Poly(DT 8, 8) wIth 10% PNA . 
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Figure C.2 DeS result for I hours mcuated Poly(DT 8, 8) with 10% PNA. 
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Figure C.3 DeS result for 2 hours incuated Poly(DT 8, 8) with 10% PNA. 
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FIgure C.4 DCS result for 3 hours mcuated Poly(DT 8, 8) WIth 10% PNA. 
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FIgure C.S DCS result for 4 hours mcuated Poly(DT 8, 8) wIth 10% PNA. 
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FIgure C.6 DeS result for 6 hours !neuated Poly(DT 8, 8) wIth 10% PNA. 
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FIgure C.7 DeS result for 8 hours meuated Poly(DT 8, 8) wIth 10% PNA. 
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Figure C.8 DCS result for 18 hours Incuated Poly(DT 8, 8) with 10% PNA. 
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Figure C.9 DCS result for 24 .hours mcuated Poly(DT 8, 8) with 10% PNA. 
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FIgure C.lO DCS result for 43 hours mcuated Poly(DT 8, 8) with 10% PNA. 
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FIgure C.Il DCS result for 48 hours mcuated Poly(DT 8, 8) with 10% PNA. 
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Figure C.12 Des result for 54 hours mcuated Poly(DT 8, 8) with 10% PNA. 
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Figure C.14 DCS result for 120 hours incuated Poly(DT 8, 8) with 10% PNA. 
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Figure C.1S DeS result for 216 hours mcuated Poly(DT 8, 8) with 10% PNA. 
APPENDIXD 
RAW DATA OF DSC RESULTS OF POLY(DT 8, 8) WITH 0% DRUG 
LOADING UNDER VACUUM CONDITIONS 
Dse results of 0% p-nitroaniline loaded Poly(DT 8, 8) under vacuum conditions and 
measured enthalpy of phase change. 
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Figure D.I DeS result for 0 hours mcuated Poly(DT 8, 8) with 0% PNA under dry 
conditions. 
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Figure D.2 DeS result for 1 hours mcuated Poly(DT 8, 8) wIth 0% PNA under dry 
conditions. 
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Figure D.3 DeS result for 2 hours incuated Poly(DT 8, 8) with 0% PNA under dry 
conditions. 
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Figure D.4 DeS result for 4 hours mcuated Poly(DT 8, 8) with 0% PNA under dry 
conditions. 
0.2 
I 
, 0' 
01 
~ 
Ol 
~ 0.0 
~ 
0 
LL 
ro -{J .1 
Q) 
:r: 
, 
. 
-0.2 
SO.66·C 
1.~1 C.ll$l 
·0.3 \£"'C 
• 0 0 20 40 60 80 100 .20 1 0 
E.<o Uc Temperature (OC) Unr.erHI V4 oc T A InHumen 
Figure D.S DeS result for 6 hours mcuated Poly(DT 8, 8) with 0% PNA under dry 
conditions. 
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Figure D.6 DCS result for 19 hours mcuated Poly(DT 8, 8) with 0% PNA under dry 
conditions. 
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Figure D.7 DCS result for 24 hours mcuated Poly(DT 8, 8) with 0% PNA under dry 
conditions. 
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Figure D.8 DCS result for 48 hours mcuated Poly(DT 8, 8) with 0% PNA under dry 
conditions. 
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Figure D.9 DCS result for 72 hours !ncuated Poly(DT 8, 8) with 0% PNA under dry 
conditions. 
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Figure D.10 DCS result for 120 hours mcuated Poly(DT 8, 8) with 0% PNA under 
dry conditions. 
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Figure D.11 DCS result for 168 hours mcuated Poly(DT 8, 8) with 0% PNA under 
dry conditions . 
APPENDIXE 
RAW DATA OF DSC RESULTS OF POLY(DT 12, 10) WiTH 0% DRUG 
LOADING 
Dse results of 0% p-nitroaniline loaded Poly(DT 12, 10) and measured enthalpy of 
phase change. 
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Figure E.1 DeS result for 0 hours mcuated Poly(DT 12, 10) with 0% PNA . 
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FIgure E.2 DeS result for 2 hours mcuated Poly(DT 12, 10) wIth 0% PNA. 
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FIgure E.3 DCS result for 3 hours mcuated Poly(DT 12, 10) wIth 0% PNA. 
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Figure E.4 DeS result for 7 hours mcuated Poly(DT 12, 10) with 0% PNA. 
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Figure E.5 DeS result for 20 hours mcuated Poly(DT 12, 10) with 0% PNA. 
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FIgure E.6 DCS result for 22 hours 59 mm mcuated Poly(DT 12, 10) wIth 0% PNA. 
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FIgure E.7 DCS result for 26 hours 59 mm mcuated Poly(DT 12, 10) wIth 0% PNA. 
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Figure E.8 DeS result for 30 hours 59 mm mcuated Poly(DT 12, 10) with 0% PNA. 
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Figure E.9 DeS result for 44 hours 59 mm mcuated Poly(DT 12, 10) with 0% PNA. 
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FIgure E.IO DCS result for 50 hours mcuated Poly(DT 12, 10) with 0% PNA. 
0.5 
0.0 I 
'-... 
eO.32'C 
, 
2SA .... 
~ \ ( ~ " .5 
c;: 
;; 
• 1: 
· 1.0 
62.45'C 
·1.5 
·0 6 20 40 60 60 '00 ,~ 140 
"" u, Temperature ("C) 
.. 
UnIvetHl \I" .OC T41nW11m«1:t 
FIgure E.ll DCS result for 5-5 hours 44 mm mcuated Poly(DT 12, 10) wIth 0% PNA . 
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Figure E.12 DCS result for 69 hours mcuated Poly(DT 12, 10) with 0% PNA. 
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Figure E.13 DCS result for 75 hours mcuated Poly(DT 12, 10) with 0% PNA. 
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Figure E.14 DeS result for 124 hours 7 mm mcuated Poly(DT 12, 10) with 0% PNA. 
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Figure E.15 DeS result for 144 hours 4 mm mcuated Poly(DT 12, 10) with 0% PNA. 
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APPENDIXF 
RAW DATA OF DSC RESULTS OF POLY(DT 12, 10) WITH 5% DRUG 
LOADING 
Dse results of 5% p-nitroaniline loaded Poly(DT 12, 10) and measured enthalpy of 
phase change. 
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Figure F.2 DeS result for I hours mcuated Poly(DT 12, 10) with 5% PNA. 
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Figure F.3 DeS result for 2 hours mcuated Poly(DT 12, 10) with 5% PNA. 
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Figure F.4 DCS result for 3 hours mcuated Poly(DT 12, 10) with 5% PNA. 
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Figure F.S DCS result for 4 hours mcuated Poly(DT 12, 10) with 5% PNA. 
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Figure F.6 DCS result for 6 hours mcuated Poly(DT 12, 10) with 5% PNA. 
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Figure F.7 DCS result for 19 hours mcuated Poly(DT 12, 10) with 5% PNA. 
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Figure F.9 DCS result for 72 hours mcuated Poly(DT 12, 10) with 5% PNA. 
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DSC results of 10% p-nitroaniline loaded Poly(DT 12, 10) and measured enthalpy of 
phase change. 
0.2 
0.0 
rn ·(1.2 
~ 
48.32"C 
~ .(14 29.5&JIg 
lJ.. \l ( -ro Ql 
I .(I·6 
.(IS ~c f .-
-1.0 
· 0 6 20 40 60 80 160 llo I 0 
"'0"" Temperature (OC) l.InIwefMi V4.OC TAo InMn.ornen:a 
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Figure G.3 DeS result for 2 hours mcuated Poly(DT 12, 10) With 10% PNA. 
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Figure G.6 DeS result for 6 hours mcuated Poly(DT 12, 10) with 10% PNA. 
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Figure G.7 DeS result for 19 hours mcuated Poly(DT 12, 10) with 10% PNA. 
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Figure G.9 DCS result for 72 hours mcuated Poly(DT 12, 10) with 10% PNA. 
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Figure G.ll DCS result for 120 hours mcuated Poly(DT 12, 10) wIth 10% PNA. 
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